Author:
Kirwan John R.,Boers Maarten,Tugwell Peter
Abstract
The Outcome Measures in Rheumatology (OMERACT) community strives to develop core outcome sets for rheumatologic conditions to specify, for each condition, the minimum set of outcomes necessary to provide consistent estimates of the benefits of an intervention. The original and successful OMERACT filter of “truth, discrimination, and feasibility” requires development and updating because of application to a widening range of conditions by an expanding group, particularly patients. It should more explicitly identify the relevant core outcomes that might be universal to all randomized controlled trials within rheumatology. Working from first principles, comparing proposals against actual procedures adopted by OMERACT working groups, and seeking a broad consensus over several major sessions at the OMERACT 11 meeting, a new version has emerged, OMERACT Filter 2.0, which will form the central theme of the intended OMERACT handbook and offers an approach to core outcome set development in many areas of healthcare.
Publisher
The Journal of Rheumatology
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference16 articles.
1. OMERACT: An international initiative to improve outcome measurement in rheumatology
2. The OMERACT Filter for outcome measures in rheumatology;Boers;J Rheumatol,1998
3. OMERACT Website . [Internet. Accessed December 13, 2013.] Available from www.omeract.org
4. Outcomes from the Patient Perspective Workshop at OMERACT 6;Kirwan;J Rheumatol,2003
5. Developing core outcome sets for clinical trials: issues to consider
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献